Literature DB >> 1592886

Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer.

F Pacini1, L Fugazzola, F Lippi, C Ceccarelli, R Centoni, P Miccoli, R Elisei, A Pinchera.   

Abstract

We studied the feasibility of employing the measurement of thyroglobulin (Tg) in the washout of the needle used to perform the fine needle aspiration cytology (FNA-Tg) for the differential diagnosis of nonthyroidal neck masses of unknown etiology. We studied 35 patients presenting for 1 or more neck lumps outside the thyroid gland. A previous history of treated differentiated thyroid cancer (DTC) was given by 23 patients and of nonthyroidal malignancy by 3 patients. FNA-Tg was measured in the Tg-free serum used to wash out the needle employed for the cytology. Finally, all patients were treated by surgery. FNA-Tg was always detectable in 14 patients with thyroid cancer metastases demonstrated by histology, with a mean (+/- SD) of 27,087 +/- 37,622 ng/FNA (P less than 0.002) compared to patients without thyroid cancer metastases (mean +/- SD, 12.1 +/- 4.8 ng/FNA in 7 cases; undetectable in 14 cases). Assuming 21.7 ng/FNA (the mean +/- 2 SD of the negative patients) as the cut-off value, all patients with metastases from DTC were detected by FNA-Tg. FNA-Tg had better negative predictive value than cytology, since this last technique gave 10 inconclusive results, comprising 2 false negative results in patients with metastases from DTC. Our results indicate that elevated concentrations of FNA-Tg in nonthyroidal neck nodes strongly suggest the diagnosis of metastases from DTC.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592886     DOI: 10.1210/jcem.74.6.1592886

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  52 in total

1.  Usefulness of thyroglobulin measurement in needle washouts of fine-needle aspiration biopsy for the diagnosis of cervical lymph node metastases from papillary thyroid cancer before thyroidectomy.

Authors:  Dae-Weung Kim; Se Jeong Jeon; Chang Guhn Kim
Journal:  Endocrine       Date:  2012-02-18       Impact factor: 3.633

2.  Diagnostic value of thyroglobulin measurement in fine-needle aspiration biopsy for detecting metastatic lymph nodes in patients with papillary thyroid carcinoma.

Authors:  Artür Salmaslıoğlu; Yeşim Erbil; Gamze Cıtlak; Feyzullah Ersöz; Serkan Sarı; Aydemir Olmez; Mehtap Tunacı; Dilek Yılmazbayhan; Neşe Colak; Selçuk Ozarmağan
Journal:  Langenbecks Arch Surg       Date:  2010-10-30       Impact factor: 3.445

Review 3.  Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

Authors:  Megan R Haymart; Nazanene H Esfandiari; Michael T Stang; Julia Ann Sosa
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

4.  Lymph node metastasis from undiagnosed occult papillary thyroid cancer.

Authors:  Antonella Carbone; Pasquale Bellitti; Rocco Bruno
Journal:  Endocrine       Date:  2013-07-11       Impact factor: 3.633

5.  Current concepts and future directions in differentiated thyroid cancer.

Authors:  Donald S A McLeod
Journal:  Clin Biochem Rev       Date:  2010-02

Review 6.  Advances in the follow-up of differentiated or medullary thyroid cancer.

Authors:  Rossella Elisei; Aldo Pinchera
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

7.  Comparison of the diagnostic performances of US-guided fine needle aspiration cytology and thyroglobulin measurement for lymph node metastases in patients with differentiated thyroid carcinoma: a meta-analysis.

Authors:  Rong-Bin Liu; Da-Lei Zhou; Bo-Heng Xu; Xin-Hua Yang; Qing Liu; Xiao Zhang; Tao Tang; Zu-Lu Ye; Yue Li
Journal:  Eur Radiol       Date:  2020-10-30       Impact factor: 5.315

8.  Diagnosis: Thyroglobulin in fine-needle aspirates-a clue to metastasis?

Authors:  Giuseppe Costante; Sebastiano Filetti
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

9.  Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer.

Authors:  A S Alzahrani; H Raef; A Sultan; S Al Sobhi; S Ingemansson; M Ahmed; A Al Mahfouz
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

10.  Cervical masses as manifestation of papillary thyroid carcinomas </=10 mm in diameter, in patients with unknown thyroid disease.

Authors:  Kalliopi Pazaitou-Panayiotou; Maria Alevizaki; Maria Boudina; Apostolos Drimonitis; Anastasia Kiziridou; Iraklis Vainas
Journal:  Thyroid Res       Date:  2008-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.